BCL7A and depressive symptom measurement: The results showed that the expression levels of GRB10 and TDRD9 were significantly increased in depression patients compared to the control group, while the expression levels of BCL7A, GPR18, KLRG1, and THEM4 were significantly decreased, all with statistical significance (Figure 5A).